Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
Hält derzeit Positionen bei Equillium Inc, Castle Biosciences Inc, Intercept Pharmaceuticals Inc, Biocon Ltd and Syngene International Ltd
| 30 Tage | Letzte 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | 5% | 8.2% | 15.1% |
| Erfolgsquote | 100% | 68% | 82% |
| Transaktionen |
1
0% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Executive Chairman of the Board | Equillium Inc | 1. Januar 2020 - |
| Independent Chairman of the Board | Castle Biosciences Inc | 1. September 2014 - |
| Independent Director | Intercept Pharmaceuticals Inc | 1. Juli 2016 - |
| Non-Executive Independent Director | Biocon Ltd | 25. April 2013 - |
| Non-Executive Independent Director | Syngene International Ltd | None - |
| Chairman of the Board, Chief Executive Officer | Equillium Inc | 1. Juni 2018 - 1. Januar 2020 |
| Independent Director | Corcept Therapeutics Inc | 10. Oktober 2012 - 18. Juni 2019 |
| Independent Director | Geron Corp | 26. September 2012 - 14. Mai 2019 |
| Chairman of the Board | Equillium Inc | 1. März 2017 - 1. Juni 2018 |
| Independent Director | Illumina Inc | 1. Januar 2004 - 30. Mai 2017 |
| Lead Independent Director | BioMed Realty Trust Inc | 1. Februar 2015 - 27. Januar 2016 |
| Director | BioMed Realty Trust Inc | 1. Januar 2013 - 1. Februar 2015 |
| President, Chief Executive Officer, Director | Amylin Pharmaceuticals LLC | 1. März 2007 - 8. August 2012 |